Cardiovascular Diseases, Obesity
Conditions
Keywords
motivation, healthy volunteers, patient compliance, exercise
Brief summary
The purpose of this study is to test in overweight and inactive adults whether the new PAI eHealh APP leads to better adherence to a physical activity regimen than the wearable step counter App from the market leader FitBit, and to evaluate if improved adherence will be reflected in a better cardiovascular profile in this group.
Interventions
DEVICEPai APP
prescribed 100 PAI weekly
DEVICEFitBit APP
prescribed 10000 steps daily
Sponsors
Norwegian University of Science and Technology
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
30 Years to 50 Years
Healthy volunteers
No
Inclusion criteria
* Body mass index \> 25 * self reported exercise one time or less per week
Exclusion criteria
* inability to use a SmartPhone * illness or disabilities that preclude or hinder completion of the study * cancer that makes participation impossible or exercise contraindicated (considered individually, in consultation with physician) * test results indicating that study participation is unsafe * participation in other studies conflicting with participation in this study * symptomatic valvular, hypertrophic cardiomyopathy, unstable angina, primary pulmonary hypertension, uncontrolled hypertension, heart failure or sever arrhythmia * diagnosed dementia * chronic communicable infectious diseases * Bariatric surgery * Medication for thyroid disease, diabetes, blood pressure or lipid lowering medication
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The proportion of the participants obtaining 80 % or more of the prescribed physical activity for one year | 1 year | Prescribed 100 PAI weekly (PAI app group), or 10 000 steps daily (step counter app) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cardiorespiratory fitness | 1 year | Peak oxygen uptake assessed by Jaeger oxycon pro; Erich Jaeger GmbH, Hoechberg, Germany |
| Resting blood pressure | 16 weeks | Left upper arm, right upper arm, orthostatic hypotension |
| Resting heart rate | 16 weeks | — |
| Body mass index | 16 weeks | Height, weight |
| Waist line | 16 weeks | in centimeters |
| Body composition | 16 weeks | body composition measured by bioelectrical impedance (InBody 720, BIOSPACE, Seoul, Korea) |
| concentration of total cholesterol in blood | 16 weeks | — |
| glucose concentration in blood | 16 weeks | — |
| glycosylated haemoglobin (HbA1c) concentration in blood | 16 weeks | — |
| c-peptide concentration in blood | 16 weeks | — |
| concentration of triglycerides in blood serum | 16 weeks | — |
| concentration of low density lipid (LDL) cholesterol in blood | 16 weeks | — |
| concentration of high density lipid (HDL) cholesterol in blood | 16 weeks | — |
| Activity questionnaire | 16 weeks | HUNT-1 questionnaire 2 exercise |
Countries
Norway
Outcome results
None listed